{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:57Z","timestamp":1792788177875,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation Project of Chongqing","award":["CSTB2023BSCQ-MSX0098"],"award-info":[{"award-number":["CSTB2023BSCQ-MSX0098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03315-7","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:26:19Z","timestamp":1761798379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The global burden and trends of esophageal cancer caused by smoking among men from 1990 to 2021 and projections to 2040: An analysis of the Global Burden of Disease 2021"],"prefix":"10.1186","volume":"30","author":[{"given":"Zhenrui","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"10466","key":"3315_CR1","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(24)02226-8","volume":"404","author":"H Yang","year":"2024","unstructured":"Yang H, Wang F, Hallemeier CL, Lerut T, Fu J. Oesophageal cancer. Lancet (London, England). 2024;404(10466):1991\u20132005.","journal-title":"Lancet (London, England)"},{"key":"3315_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"2","key":"3315_CR3","first-page":"289","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP. Different strategies for cancer treatment: Targeting cancer cells or their neighbors? Chin J Cancer Res Chung-kuo yen cheng yen chiu. 2025;37(2):289\u201392.","journal-title":"Chin J Cancer Res Chung-kuo yen cheng yen chiu"},{"issue":"9","key":"3315_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41419-024-06986-y","volume":"15","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Zhang H, Du J, Yang J, Pan W, Zhang Q, et al. A spatiotemporal comparative analysis on tumor immune microenvironment characteristics between neoadjuvant chemotherapy and preoperative immunotherapy for ESCC. Cell Death Dis. 2024;15(9):663.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3315_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/CBM-220143","volume":"35","author":"H Liu","year":"2022","unstructured":"Liu H, Li Y. Potential roles of Cornichon Family AMPA Receptor Auxiliary Protein 4 (CNIH4) in head and neck squamous cell carcinoma. Cancer Biomark Sect A Dis Mark. 2022;35(4):439\u201350.","journal-title":"Cancer Biomark Sect A Dis Mark"},{"issue":"3","key":"3315_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/CBM-210340","volume":"34","author":"Y Li","year":"2022","unstructured":"Li Y, Liu H. Clinical powers of aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma. Cancer Biomark Sect A Dis Mark. 2022;34(3):359\u201374.","journal-title":"Cancer Biomark Sect A Dis Mark"},{"issue":"11","key":"3315_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11894-023-00899-0","volume":"25","author":"S Lander","year":"2023","unstructured":"Lander S, Lander E, Gibson MK. Esophageal cancer: overview, risk factors, and reasons for the rise. Curr Gastroenterol Rep. 2023;25(11):275\u20139.","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"3315_CR8","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3315_CR9","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3315_CR10","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/ijc.25885","volume":"129","author":"F Islami","year":"2011","unstructured":"Islami F, Fedirko V, Tramacere I, Bagnardi V, Jenab M, Scotti L, et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer. 2011;129(10):2473\u201384.","journal-title":"Int J Cancer"},{"issue":"3","key":"3315_CR11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/ije\/dyv175","volume":"45","author":"ND Freedman","year":"2016","unstructured":"Freedman ND, Abnet CC, Caporaso NE, Fraumeni JF Jr, Murphy G, Hartge P, et al. Impact of changing US cigarette smoking patterns on incident cancer: risks of 20 smoking-related cancers among the women and men of the NIH-AARP cohort. Int J Epidemiol. 2016;45(3):846\u201356.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"3315_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/ajg.2014.71","volume":"109","author":"A Prabhu","year":"2014","unstructured":"Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109(6):822\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"3315_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jjco\/hyr170","volume":"42","author":"I Oze","year":"2012","unstructured":"Oze I, Matsuo K, Ito H, Wakai K, Nagata C, Mizoue T, et al. Cigarette smoking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2012;42(1):63\u201373.","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"3315_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.canlet.2008.10.020","volume":"275","author":"S Ishiguro","year":"2009","unstructured":"Ishiguro S, Sasazuki S, Inoue M, Kurahashi N, Iwasaki M, Tsugane S, et al. Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study). Cancer Lett. 2009;275(2):240\u20136.","journal-title":"Cancer Lett"},{"issue":"10440","key":"3315_CR15","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England). 2024;403(10440):2133\u201361.","journal-title":"Lancet (London, England)"},{"issue":"10258","key":"3315_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"GBD 2019 Demographics Collaborators","year":"2020","unstructured":"GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the global burden of disease study 2019. Lancet (London, England). 2020;396(10258):1160\u2013203.","journal-title":"Lancet (London, England)"},{"issue":"7","key":"3315_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18457","volume":"4","author":"MCS Wong","year":"2021","unstructured":"Wong MCS, Huang J, Chan PSF, Choi P, Lao XQ, Chan SM, et al. Global incidence and mortality of Gastric cancer, 1980\u20132018. JAMA Netw Open. 2021;4(7):e2118457.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"3315_CR18","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/(SICI)1097-0258(19980630)17:12<1305::AID-SIM853>3.0.CO;2-W","volume":"17","author":"C Robertson","year":"1998","unstructured":"Robertson C, Boyle P. Age-period-cohort analysis of chronic disease rates. I: modelling approach. Stat Med. 1998;17(12):1305\u201323.","journal-title":"Stat Med"},{"issue":"3","key":"3315_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"issue":"18","key":"3315_CR20","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/sim.3850","volume":"29","author":"VM Muggeo","year":"2010","unstructured":"Muggeo VM. Comment on \u201cestimating average annual per cent change in trend analysis\u201d by Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK, Statistics in medicine 2009; 28:3670\u20133682. Stat Med. 2010;29(18):1958\u201361.","journal-title":"Stat Med"},{"issue":"5","key":"3315_CR21","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1002\/ehf2.14915","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li Z, Li X, Yan Y, Liu J, Wang J, et al. Global trends in heart failure from 1990 to 2019: an age-period-cohort analysis from the Global Burden of Disease study. ESC Heart Fail. 2024;11(5):3264\u201378.","journal-title":"ESC Heart Fail"},{"issue":"11","key":"3315_CR22","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomark Prevent. 2014;23(11):2296\u2013302.","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"9","key":"3315_CR23","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/sim.3041","volume":"27","author":"J Rosenbauer","year":"2008","unstructured":"Rosenbauer J, Strassburger K. Comments on \u201cage-period-cohort models for the Lexis diagram\u201d by Carstensen B. statistics in medicine 2007; 26:3018\u20133045. Stat Med. 2008;27(9):1557\u201364.","journal-title":"Stat Med"},{"issue":"6","key":"3315_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103326","volume":"22","author":"F Cao","year":"2023","unstructured":"Cao F, He YS, Wang Y, Zha CK, Lu JM, Tao LM, et al. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023;22(6):103326.","journal-title":"Autoimmun Rev"},{"key":"3315_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102829","volume":"76","author":"Z Luo","year":"2024","unstructured":"Luo Z, Shan S, Cao J, Zhou J, Zhou L, Jiang D, et al. Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021. EClinicalMedicine. 2024;76:102829.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"3315_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16199","volume":"45","author":"S Lei","year":"2025","unstructured":"Lei S, Huang G, Li X, Xi P, Yao Z, Lin X. Global burden, trends, and inequalities of gallbladder and biliary tract cancer, 1990\u20132021: a decomposition and age-period-cohort analysis. Liver Int. 2025;45(2):e16199.","journal-title":"Liver Int"},{"issue":"1","key":"3315_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/JS9.0000000000001902","volume":"111","author":"Z Bai","year":"2025","unstructured":"Bai Z, Wang H, Shen C, An J, Yang Z, Mo X. The global, regional, and national patterns of change in the burden of nonmalignant upper gastrointestinal diseases from 1990 to 2019 and the forecast for the next decade. Int J Surg (London, England). 2025;111(1):80\u201392.","journal-title":"Int J Surg (London, England)"},{"issue":"4","key":"3315_CR28","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1016\/S2468-2667(17)30045-2","volume":"2","author":"S Gravely","year":"2017","unstructured":"Gravely S, Giovino GA, Craig L, et al. Implementation of key demand-reduction measures of the WHO framework convention on tobacco control and change in smoking prevalence in 126 countries: an association study. Lancet Public Health. 2017;2(4):e166\u201374.","journal-title":"Lancet Public Health"},{"issue":"5","key":"3315_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.21147\/j.issn.1000-9604.2021.05.01","volume":"33","author":"J Li","year":"2021","unstructured":"Li J, Xu J, Zheng Y, et al. Esophageal cancer: epidemiology, risk factors and screening. Chin J Cancer Res. 2021;33(5):535\u201347.","journal-title":"Chin J Cancer Res"},{"issue":"8","key":"3315_CR30","first-page":"656","volume":"21","author":"Y Teng","year":"2024","unstructured":"Teng Y, Xia C, Cao M, et al. Esophageal cancer global burden profiles, trends, and contributors. Cancer Biol Med. 2024;21(8):656\u201366.","journal-title":"Cancer Biol Med"},{"key":"3315_CR31","doi-asserted-by":"crossref","unstructured":"Jiao Y, Wang T, Fu L, et al. Trends, patterns, and risk factors of esophageal cancer mortality in China, 2008\u20132021: A National Mortality Surveillance System data analysis. J Adv Res. Published online May 15, 2025.","DOI":"10.1016\/j.jare.2025.05.021"},{"issue":"3","key":"3315_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11748-023-01987-8","volume":"72","author":"G Wu","year":"2024","unstructured":"Wu G, Wu Q, Xu J, Gao G, Chen T, Chen G. Mortality burden and future projections of major risk factors for esophageal cancer in China from 1990 to 2019. Gen Thorac Cardiovasc Surg. 2024;72(3):192\u2013201.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"3315_CR33","doi-asserted-by":"publisher","first-page":"1223164","DOI":"10.3389\/fonc.2023.1223164","volume":"13","author":"S Wu","year":"2023","unstructured":"Wu S, Jiang W, Li J, Wu Z, Xu C, Xie N. Global burden of esophageal cancer attributable to smoking: a systematic analysis for the Global Burden of Disease Study 2019. Front Oncol. 2023;13:1223164 (Published 2023 Aug 9).","journal-title":"Front Oncol"},{"key":"3315_CR34","doi-asserted-by":"publisher","first-page":"102163","DOI":"10.1016\/j.eclinm.2023.102163","volume":"63","author":"S Song","year":"2023","unstructured":"Song S, Lei L, Liu H, et al. Impact of changing the prevalence of smoking, alcohol consumption and overweight\/obesity on cancer incidence in China from 2021 to 2050: a simulation modelling study. EClinicalMedicine. 2023;63:102163 (Published 2023 Aug 18).","journal-title":"EClinicalMedicine."},{"issue":"10082","key":"3315_CR35","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","volume":"389","author":"GBD 2015 Tobacco Collaborators","year":"2017","unstructured":"GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990\u20132015: a systematic analysis from the global burden of disease study 2015 [published correction appears in Lancet. 2017 Oct 7;390(10103):1644. doi: 10.1016\/S0140-6736(17)32559-X.]. Lancet. 2017;389(10082):1885\u2013906.","journal-title":"Lancet"},{"issue":"6","key":"3315_CR36","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S2468-1253(20)30007-8","volume":"5","author":"GBD 2017 Oesophageal Cancer Collaborators","year":"2020","unstructured":"GBD 2017 Oesophageal Cancer Collaborators. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(6):582\u201397.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"35","key":"3315_CR37","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.3748\/wjg.v24.i35.3965","volume":"24","author":"S Malik","year":"2018","unstructured":"Malik S, Sharma G, Sanaka MR, Thota PN. Role of endoscopic therapy in early esophageal cancer. World J Gastroenterol. 2018;24(35):3965\u201373.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"3315_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042281","volume":"7","author":"JB Wang","year":"2012","unstructured":"Wang JB, Fan JH, Liang H, et al. Attributable causes of esophageal cancer incidence and mortality in China. PLoS ONE. 2012;7(8):e42281.","journal-title":"PLoS ONE"},{"issue":"Suppl 2","key":"3315_CR39","doi-asserted-by":"publisher","first-page":"s81","DOI":"10.1136\/tobaccocontrol-2018-054429","volume":"28","author":"P Puska","year":"2019","unstructured":"Puska P, Daube M, WHO FCTC Impact Assessment Expert Group. Impact assessment of the WHO framework convention on tobacco control: introduction, general findings and discussion. Tob Control. 2019;28(Suppl 2):s81\u20133.","journal-title":"Tob Control"},{"issue":"2","key":"3315_CR40","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.21873\/anticanres.14047","volume":"40","author":"T Aoyama","year":"2020","unstructured":"Aoyama T, Hara K, Kazama K, et al. The short- and long-term outcomes of esophagectomy for esophageal cancer in patients older than 75 years. Anticancer Res. 2020;40(2):1087\u201393.","journal-title":"Anticancer Res"},{"issue":"1","key":"3315_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","volume":"63","author":"RC Fitzgerald","year":"2014","unstructured":"Fitzgerald RC, di Pietro M, Ragunath K, et al. British society of gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus. Gut. 2014;63(1):7\u201342.","journal-title":"Gut"},{"key":"3315_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx115","author":"QL Wang","year":"2017","unstructured":"Wang QL, Xie SH, Li WT, Lagergren J. Smoking cessation and risk of esophageal cancer by histological type: systematic review and meta-analysis. J Natl Cancer Inst. 2017. https:\/\/doi.org\/10.1093\/jnci\/djx115.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3315_CR43","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1038\/s41598-025-94050-w","volume":"15","author":"G Gulis","year":"2025","unstructured":"Gulis G, Zidkova R, Meier Z. Changes in disease burden and epidemiological transitions. Sci Rep. 2025;15(1):8961 (Published 2025 Mar 15).","journal-title":"Sci Rep"},{"issue":"12","key":"3315_CR44","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1016\/S1470-2045(13)70350-4","volume":"14","author":"AA Lertkhachonsuk","year":"2013","unstructured":"Lertkhachonsuk AA, Yip CH, Khuhaprema T, et al. Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol. 2013;14(12):e497\u2013507.","journal-title":"Lancet Oncol"},{"issue":"4","key":"3315_CR45","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.4251\/wjgo.v16.i4.1180","volume":"16","author":"HT Qu","year":"2024","unstructured":"Qu HT, Li Q, Hao L, et al. Esophageal cancer screening, early detection and treatment: current insights and future directions. World J Gastrointest Oncol. 2024;16(4):1180\u201391.","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"3315_CR46","first-page":"1019","volume":"42","author":"L Hengrui","year":"2022","unstructured":"Hengrui L. Toxic medicine used in Traditional Chinese Medicine for cancer treatment: are ion channels involved? J Tradit Chin Med. 2022;42(6):1019\u201322.","journal-title":"J Tradit Chin Med"},{"issue":"1","key":"3315_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13020-024-01018-5","volume":"19","author":"Z Xu","year":"2024","unstructured":"Xu Z, Rasteh AM, Dong A, Wang P, Liu H. Identification of molecular targets of Hypericum perforatum in blood for major depressive disorder: a machine-learning pharmacological study. Chin Med. 2024;19(1):141 (Published 2024 Oct 9).","journal-title":"Chin Med"},{"issue":"20","key":"3315_CR48","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i20.106443","volume":"31","author":"HR Liu","year":"2025","unstructured":"Liu HR. Harnessing traditional medicine and biomarker-driven approaches to counteract Trichostatin A-induced esophageal cancer progression. World J Gastroenterol. 2025;31(20):106443.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"3315_CR49","first-page":"209","volume":"43","author":"L Hengrui","year":"2023","unstructured":"Hengrui L. An example of toxic medicine used in Traditional Chinese Medicine for cancer treatment. J Tradit Chin Med. 2023;43(2):209\u201310.","journal-title":"J Tradit Chin Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03315-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03315-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03315-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:02:31Z","timestamp":1761804151000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03315-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3315"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03315-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The GBD 2021 study is an open database, and all data is anonymous.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1043"}}